Human medicines European public assessment report (EPAR): Triumeq, abacavir,dolutegravir,lamivudine, Date of authorisation: 31/08/2014, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Zegalogue, dasiglucagon, Date of authorisation: 24/07/2024, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 16, Status: Authorised
Medical device expert panels
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 January 2026, 15:00 (CET) to 15 January 2026, 16:00 (CET)
EVVet3 EVWeb Production - Release notes
Agenda - Webinar on the use of platform technologies in the non-clinical and clinical domains
European Medicines Agency’s data protection notice for the EudraVigilance Signal and Safety Analytics (EV SSA) platform
Questions and answers on the use of Product Lifecycle Management (PLCM) document - Scientific guideline